LUMOS PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.04 USD | +0.66% |
|
+10.14% | -4.40% |
| 07/03 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 07/03 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
Chart calendar Lumos Pharma, Inc.
fb96dcf52350649407.cTS24A9VSuPdzjzt1uYIqLHNS7EdKyX-7NPLKn5azDQ.C37FkWQGJ7uJnX_Vn7w7mcWsJftEXU-9vIGvWT9o9GY-cI6KemR8hr6faQ~e893d7c3472721beecc46837daa283e5
Upcoming events on Lumos Pharma, Inc.
Past events on Lumos Pharma, Inc.
| 01/05/2024 | Q1 2024 Earnings Release (Projected) |
| 08/03/2024 03:00 am | Q4 2023 Earnings Call |
| 08/03/2024 02:31 am | Q4 2023 Earnings Release |
| 14/02/2024 07:50 pm | Oppenheimer Healthcare Life Sciences Conference |
| 07/12/2023 12:00 am | Investor Meeting - Key Opinion Leaders |
| 01/12/2023 01:00 am | Piper Sandler Healthcare Conference |
| 08/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 08/11/2023 02:31 am | Q3 2023 Earnings Release |
| 28/09/2023 10:45 pm | Cantor Global Healthcare Conference |
| 23/09/2023 01:00 pm | European Society for Paediatric Endocrinology Meeting |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 05/09/2023 08:30 pm | Investor Meeting - Key Opinion Leaders |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 10/08/2023 01:31 am | Q2 2023 Earnings Release |
| 18/07/2023 | Oppenheimer Life Sciences Summit |
| 21/06/2023 08:30 pm | Investor Meeting - Key Opinion Leader |
| 18/06/2023 02:00 am | Endocrine Society Meeting - Abstract 6014 |
| 18/06/2023 02:00 am | Endocrine Society Meeting - Abstract 6273 |
| 09/06/2023 09:00 pm | Jefferies Global Healthcare Conference |
| 07/06/2023 12:15 am | BIO International Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,17 0,14 21.74% | 0,23 0,01 2200% | 1,52 1,14 33.15% | 2,05 1,22 68.05% | 8,81 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,82 -9,91 0.93% | -26,3 -27,3 3.7% | -31,3 -32,6 3.85% | -32,0 -31,7 -1.05% | -36,6 -36,4 -0.69% | -36,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -19,6 -20,4 3.68% | -31,1 -32,6 4.75% | -31,1 -31,2 0.52% | -34,1 -34,2 0.41% | -35,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -6,31 -10,9 41.98% | -30,4 -32,6 6.7% | -31,1 -31,2 0.56% | -34,0 -34,2 0.45% | -35,4 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -0,93 -1,50 37.92% | -3,65 -3,89 6.27% | -3,71 -3,64 -2.04% | -4,18 -4,05 -3.15% | -2,81 |
| Announcement Date | 01/06/20 | 09/03/21 | 10/03/22 | 01/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,22 0,00 - | 0,11 0,00 - | 0,50 0,07 645.46% | 0,51 0,14 273.18% | 0,69 | 0,53 0,20 166.5% | 0,01 0,16 -95.53% | 0,83 0,00 - | 0,30 | 8,30 | 0,10 | 0,30 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -6,57 -7,82 16.03% | -7,73 -7,58 -2.04% | -7,55 -8,52 11.35% | -8,84 -8,50 -3.9% | -8,04 -8,04 0% | -9,64 -9,07 -6.31% | -8,93 -10,0 10.86% | -10,0 -9,76 -2.53% | -9,87 | -2,54 | -11,3 | -13,0 | -12,8 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,28 -7,83 19.8% | -7,72 -7,57 -2% | -7,25 -8,49 14.64% | -8,26 -8,43 1.97% | -7,35 | -8,96 -8,93 -0.34% | -8,30 -9,87 15.9% | -9,46 -9,61 1.55% | -9,73 | -2,41 | -11,0 | -12,2 | -12,8 | |
|
Net income Million USD | Released Forecast Spread | -5,64 -7,83 27.92% | -7,72 -7,57 -2% | -7,84 | -7,25 -8,49 14.64% | -8,25 -8,43 2.12% | -7,35 | -8,93 -8,93 -0.02% | -8,30 -9,87 15.9% | -9,46 -9,61 1.55% | -9,73 | -2,41 | -11,0 | -12,2 | -12,8 |
|
EPS USD | Released Forecast Spread | -0,68 -0,92 25.93% | -0,92 -0,90 -2.22% | -0,94 | -0,86 -1,01 14.57% | -0,98 -0,92 -6.99% | -0,89 | -1,09 -1,08 -1.11% | -1,04 -1,15 9.57% | -1,17 -1,06 -10.12% | -1,18 | -0,68 | -0,66 | -0,72 | -1,20 |
| Announcement Date | 10/03/22 | 10/05/22 | 10/08/22 | 14/11/22 | 01/03/23 | 05/05/23 | 09/08/23 | 07/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Lumos Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LUMO Stock
- Calendar Lumos Pharma, Inc.
